Substance / Medication

Oxygen

Overview

Active Ingredient
oxygen
RxNorm CUI
7806
Labeler: CEE-KAY SUPPLY, INC.Updated: 2026-02-25T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

33 trials linked to this intervention

33
Total Trials
4
Recruiting
3
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of HFNC + NIV as initial oxygen therapy in acute respiratory failure: Meta-analysis.
Wang Weizhong, Zhang Pan, Xu Ting et al. · Am J Emerg Med · 2026
PMID: 41344140Meta-Analysis
Hyperlactatemia and poor outcome After postcardiotomy veno-arterial extracorporeal membrane oxygenation: An individual patient data meta-Analysis.
Biancari Fausto, Kaserer Alexander, Perrotti Andrea et al. · Perfusion · 2024
PMID: 37066850Meta-Analysis
Normal regional tissue oxygen saturation in neonates: a systematic qualitative review.
Bruckner Marlies, Wolfsberger Christina H, Dempsey Eugene M et al. · Pediatr Res · 2024
PMID: 34667270Meta-Analysis
Extracorporeal Membrane Oxygenation in Intoxication and Overdoses: A Systematic Review.
Maier Sven, Rösner Lisa, Saemann Lars et al. · Thorac Cardiovasc Surg · 2024
PMID: 36940708Meta-Analysis
Monitoring of Brain Tissue Oxygen Tension in Cardiac Arrest: a Translational Systematic Review from Experimental to Clinical Evidence.
Battaglini Denise, Bogossian Elisa Gouvea, Anania Pasquale et al. · Neurocrit Care · 2024
PMID: 37081276Meta-Analysis
Prognostic of red blood cell transfusion during extracorporeal membrane oxygenation therapy on mortality: A meta-analysis.
Li Yuan, Wang Jing, Li Chaoyang et al. · Perfusion · 2024
PMID: 36800909Meta-Analysis
Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane Oxygenation.
Kido Kazuhiko, Kabulski Galen M, Szymanski Thomas W et al. · J Pharm Pract · 2024
PMID: 36449392Meta-Analysis
Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Huang Daochao, Guan QiongChan, Qin Jie et al. · Perfusion · 2023
PMID: 35616224Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxygen (substance)
SNOMED CT
24099007
UMLS CUI
C0030054
RxNorm CUI
7806
Labeler
CEE-KAY SUPPLY, INC.

Clinical Data

This intervention maps to 14 entities in the Ltrl knowledge graph.

9
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
33
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.